MedPath

Enhancing Kidney Donation Through Live Organ Video Educated Donors (LOVED) Study Phase

Not Applicable
Completed
Conditions
Kidney Transplantation
Interventions
Behavioral: LOVED Intervention
Registration Number
NCT03599102
Lead Sponsor
Medical University of South Carolina
Brief Summary

LOVED stands for the Living Organ Video Educated Donors (LOVED) program. It is a culturally tailored program for African Americans to reduce the disparity of low rates of living kidney donation. It is a mobile health delivered platform that does not require transplant center visits, thus increasing the reach of the program compared to center-based program to enhance living kidney donation. The purpose of LOVED is to give education and encouragement to those who need a kidney transplant and teach about the process of living donation to be better educated when approaching others about donating a kidney. The ultimate goal of the program is to increase the number of living kidney donor transplants, especially among African Americans in South Carolina. The program was created to educate those in need of a kidney about the donor process, to dispel myths about living donation, discuss who can be asked to donate and develop and practice skills to start asking others for a living kidney donation. The program is designed to be completed using a tablet computer and is made up of weekly video education clips, resources, short quizzes to reinforce the learning points and weekly video chat sessions with others who need a kidney led by a "navigator" who was once a living donor kidney recipient. The video clips are made up of stories and brief educational messages from transplant center staff, physicians, former donors and recipients. The video chat sessions were designed to solve and address individual issues for those enrolled in the program and to give a sense of community as they continue on their journey to find a kidney. This randomized control trial uses groups of 6-9 participants in each LOVED group that lasts 8-weeks each. A total of 60 participants will be recruited with 30 assigned to LOVED and 30 assigned to a standard care groups. This program is funded by a grant from the National Institute of Health and was developed at the Medical University of South Carolina.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • 18-65 years old
  • African American
  • Legally competent
  • Able to read and speak in English
  • Able to use tablet computers (after instruction)
  • Able to use cell phone
  • 5 years or less on the kidney waitlist with active status including pre-emptive and ESRD patients on dialysis
  • 10 years or less on dialysis
Read More
Exclusion Criteria
  • Patients who have currently identified PDs moving through the evaluation stage
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LOVED interventionLOVED InterventionIntervention group receives the LOVED program, an 8-week program where participants receive video education modules, and weekly video chat sessions with other end-stage renal disease patients and a prior living kidney African American recipient. The program aims to increase knowledge and skills on how to promote individual strategies on how to ask for a kidney from others.
Primary Outcome Measures
NameTimeMethod
Change in self-efficacy to ask others to be a living donorChange between 0 and 8 weeks and change between 0 and 6 months

Willingness to Discuss LDKT Scale (i.e., measuring self-efficacy (SE)) (1 item each for family, friends, and strangers7 pt. Likert scale) 1-7 range with higher values representing higher SE to approach others about living donation

Change in knowledge about living donationChange between 0 and 8 weeks and change between 0 and 6 months

Score measures for self-efficacy, knowledge and attitudes to approach others to be a living donor

-LDKT Knowledge Scale (knowledge) (15 item T/F); each correct response adds 1 point. 0-15 range with higher numbers represent higher knowledge.

Participant adherence to study protocolsAssessed at 8 weeks

Tolerability as defined by % retention to study (% of participants who self-remove from the study) Fidelity as defined by %adherence to chat sessions and completion %of video modules.

Change in attitudes on living donationChange between 0 and 8 weeks and change between 0 and 6 months

LDKT Concerns Scale (i.e., measuring attitudes) (21 T/F with one point for each statement suggestive of more worry); 0-21 range with higher results representing more concerns about LDKT.

Secondary Outcome Measures
NameTimeMethod
Completing living donor kidney transplantation8 weeks, 6 months

% who identify potential donors, % elected to be screened and, % completing Living donor kidney transplantation (from clinical records compared between groups)

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath